About Aurolab
Aurolab is a company based in Madurai (India) founded in 1992 by Bala Krishnan. Aurolab offers products and services including Intraocular Lenses (IOLs), Diagnostic Equipment, Surgical Devices, and Ophthalmic Therapeutics. Aurolab operates in a competitive market with competitors including Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
- Headquarter Madurai, India
- Founders Bala Krishnan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Auro Laboratories Limited
- Date of Incorporation 26 May, 1989
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$6.44 M (USD)6.12as on Mar 31, 2024
-
Net Profit
$910.29 K (USD)173.92as on Mar 31, 2024
-
EBITDA
$1.25 M (USD)130.7as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurolab
Aurolab offers a comprehensive portfolio of products and services, including Intraocular Lenses (IOLs), Diagnostic Equipment, Surgical Devices, and Ophthalmic Therapeutics.
Products for cataract surgery to restore vision effectively.
Tools for optimizing insights in eye disease treatment.
Equipment enhancing precision in ophthalmic procedures.
Medications expanding possibilities in eye health management.
People of Aurolab
Unlock access to complete
Unlock access to complete
Funding Insights of Aurolab
Investors in Aurolab
Aurolab has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ideaship.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures are funded by Ideaship VC fund.
|
Locked | Locked | Locked |
Investor details for Aurolab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurolab
Investment portfolio details for Aurolab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurolab
Detailed financials for Aurolab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurolab Comparisons
Peer comparison for Aurolab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurolab
Aurolab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| Locked | Locked | Locked |
Digital therapeutics for myopia are developed via retinal light stimulation.
|
|
| Locked | Locked | Locked |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| Locked | Locked | Locked |
Titanium ophthalmic surgical instruments are manufactured and repaired.
|
|
| Locked | Locked | Locked |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| Locked | Locked | Locked |
Precision instruments for eye surgery are designed and manufactured.
|
Detailed competitors of Aurolab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurolab
Complete news archive for Aurolab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurolab
Aurolab was founded in 1992 and raised its 1st funding round 28 years after it was founded.
Aurolab is headquartered in Madurai, India. It is registered at Madurai, Tamil Nadu, India.
Annual revenue of Aurolab is $6.44M as on Mar 31, 2024.
Aurolab, an integral part of the Aravind Eye Care System manufactures high quality ophthalmic consumables such as intra-ocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments. Its products are exported to 130 countries worldwide, with focus markets like India, Africa, Latin America, Central America and Southeast Asia. The company has altered the eye-care industry by bringing down the price of the intra-ocular lens down to a tenth of international prices in the late 1990s and grown to market its products across 130 countries.
Aurolab's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
Aurolab offers Intraocular Lenses (IOLs), Diagnostic Equipment, Surgical Devices, and Ophthalmic Therapeutics.
Aurolab has 1 investor. Key investors include Ideaship.